[1] |
LAN Yu, WANG Fenghua.
Comparison and review of updated guidelines for advanced gastric cancer diagnosis and treatment in 2024: CSCO, NCCN and ESMO
[J]. China Oncology, 2025, 35(2): 219-227.
|
[2] |
CAI Shuyue, XIE Quan, ZHOU Yuxuan, LIU Qingzhu, QIU Ling, LIN Jianguo.
Latest progress and prospect of NRP-1 targeted molecular probes for breast cancer diagnosis
[J]. China Oncology, 2025, 35(2): 249-254.
|
[3] |
ZHAO Yihan, LI Ruochen, LIN Yansong.
Current status and prospect of diagnosis and treatment of bone metastasis of thyroid cancer
[J]. China Oncology, 2025, 35(1): 12-20.
|
[4] |
WANG Renfei, LU Gaixia.
The unique value and controversy of nuclear medicine molecular imaging in the evaluation of radioiodine-refractory differentiated thyroid cancer
[J]. China Oncology, 2025, 35(1): 49-57.
|
[5] |
Society of Neuroendocrine Neoplasm of China Anti-Cancer Association.
China Anti-Cancer Association guideline for diagnosis and treatment of neuroendocrine neoplasms (2025 edition)
[J]. China Oncology, 2025, 35(1): 85-142.
|
[6] |
Urologic Chinese Oncology Group.
Expert consensus on early diagnosis and treatment of bladder cancer (2024 edition)
[J]. China Oncology, 2024, 34(6): 607-618.
|
[7] |
Professional Committee on Gastric Cancer of Shanghai Anticancer Association , Professional Committee on Gastrointestinal Cancer of China Association for Promotion of Health Science and Technology .
Chinese expert consensus on clinical practice of locally advanced gastric cancer invading adjacent organs (2024 edition)
[J]. China Oncology, 2024, 34(5): 517-526.
|
[8] |
MA Fenghua, JIANG Anqi, CHEN Yiqing, XU Congjian, KANG Yu.
Magnetic resonance imaging for distinguishing gastric-type endocervical adenocarcinoma from lobular endocervical glandular hyperplasia
[J]. China Oncology, 2024, 34(4): 380-388.
|
[9] |
Expert Committee on Pathology of Chinese Research Hospital Association , Professional Committee on Tumor Pathology of Shanghai Anticancer Association .
Practice guideline for the histopathological diagnosis of mesothelioma (2025 version)
[J]. China Oncology, 2024, 34(12): 1144-1163.
|
[10] |
Colorectal Cancer Special Committee of Shanghai Anti-Cancer Association .
Shanghai plan for early screening, diagnosis and treatment of colorectal cancer (2023 edition)
[J]. China Oncology, 2024, 34(1): 13-66.
|
[11] |
LI Tong, YANG Huijuan.
Progress in diagnosis and treatment of mucinous ovarian cancer
[J]. China Oncology, 2024, 34(1): 90-96.
|
[12] |
XU Hongtao, HUANG Xiaojuan, ZHENG Chongyang, ZHANG Zhiyuan.
Development and progress of fluorescence imaging technology in diagnosis and treatment of oral cancer
[J]. China Oncology, 2023, 33(9): 874-878.
|
[13] |
Society of Cancer of Multiple and Unknown Primary of China Anti-Cancer Association Yuguang .
China Anti-Cancer Association guideline for diagnosis and treatment of cancer of multiple and unknown primaries (2023 edition)
[J]. China Oncology, 2023, 33(4): 403-422.
|
[14] |
ZHENG Shengfeng, ZHU Yiping, YE Dingwei.
Advances in basic research, clinical diagnosis and treatment of bladder cancer in 2022
[J]. China Oncology, 2023, 33(3): 201-209.
|
[15] |
The Society of Breast Cancer China Anti-Cancer Association, Breast Oncology Group of the Oncology Branch of the Chinese Medical Association.
Guidelines for breast cancer diagnosis and treatment by China Anti-cancer Association (2024 edition)
[J]. China Oncology, 2023, 33(12): 1092-1187.
|